Research Disclosures & Disclaimers

This website contains disclosures and disclaimers related to
published UBS Global Research products, including those related to
regulation, potential conflicts of interest as well as those provided
by third-party data providers describing limitations on use of their
products.

Woori Financial Group (316140.KS)

UBS Rating and Price Target History Chart

Line chart explaining Price target vs Stock Price is described in below table

EQ Rating & Price Target Table

Date Stock Price (Won) Price Target (Won) Rating
2021-08-201055010300Neutral
2021-10-201260012000Neutral
2022-04-281530015000Neutral
2022-09-051160011900Neutral
2022-10-191200011600Neutral
2023-05-171171012000Neutral
2024-01-221261012800Neutral
2024-05-061413013900Neutral
2024-08-2916030-No Rating

Disclosures

  • UBS has acted as manager/co-manager in the underwriting or placement of securities of this company/entity or one of its affiliates within the past 12 months.
  • UBS is acting as sole financial advisor to Dajia Insurance Group Co Ltd on its combined sales of Tong Yang Life Insurance Co Ltd and ABL Life Insurance Co Ltd to Woori Financial Group Inc.
  • Within the past 12 months, UBS has received compensation for investment banking services from this company/entity or one of its affiliates.
  • Within the past 12 months, UBS has received compensation for products and services other than investment banking services from this company/entity.
  • UBS Securities LLC makes a market in the securities and/or ADRs of this company.
  • UBS holds a long or short position of 0.5% or more of the listed shares of this company.
Note : Historical Price Targets have been adjusted to account for any stock splits, rights issues and/or dividends which may have occurred for this security. Not Priced: Stock was not priced on the given date. No Rating: Issuer was not rated by UBS on the given day. No Price Target: For this issuer no Price Target was set by UBS on the given day.